Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Construction in Progress (2021)

Historic Construction in Progress for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Q4 2021 value amounting to $139000.0.

  • Amylyx Pharmaceuticals' Construction in Progress changed N/A to $139000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $139000.0, marking a year-over-year change of. This contributed to the annual value of $139000.0 for FY2021, which is N/A changed from last year.
  • Amylyx Pharmaceuticals' Construction in Progress amounted to $139000.0 in Q4 2021.
  • Amylyx Pharmaceuticals' 5-year Construction in Progress high stood at $139000.0 for Q4 2021, and its period low was $139000.0 during Q4 2021.